Page 18 - 2022-32-中国全科医学

http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn ·3983·

DOI：10.1371/journal.pone.0075091. 10.1007/s00415-022-10993-4.
［30］KÖRTVELYESSY P，KUHLE J，DÜZEL E，et al. Ratio and index ［41］BISCHOF A，MANIGOLD T，BARRO C，et al. Serum
of Neurofilament light chain indicate its origin in Guillain-Barré neurofilament light chain: a biomarker of neuronal injury in vasculitic
Syndrome［J］. Ann Clin Transl Neurol，2020，7（11）：2213- neuropathy［J］. Ann Rheum Dis，2018，77（7）：1093-1094.
2220. DOI：10.1002/acn3.51207. DOI：10.1136/annrheumdis-2017-212045.
［31］MARIOTTO S，CARTA S，BOZZETTI S，et al. Sural nerve ［42］SANDELIUS Å，ZETTERBERG H，BLENNOW K，et al. Plasma
biopsy: current role and comparison with serum neurofilament light neurofilament light chain concentration in the inherited peripheral
chain levels［J］. J Neurol，2020，267（10）：2881-2887. neuropathies［J］. Neurology，2018，90（6）：e518-524.
DOI：10.1007/s00415-020-09949-3. DOI：10.1212/WNL.0000000000004932.
［32］LEHMANN H C，BURKE D，KUWABARA S. Chronic ［43］MAIA L F，MACESKI A，CONCEIÇÃO I，et al. Plasma
inflammatory demyelinating polyneuropathy: update on diagnosis， neurofilament light chain: an early biomarker for hereditary ATTR
immunopathogenesis and treatment［J］. J Neurol Neurosurg amyloid polyneuropathy［J］. Amyloid，2020，27（2）：97-
Psychiatry，2019，90（9）：981-987. DOI：10.1136/jnnp- 102. DOI：10.1080/13506129.2019.1708716.
2019-320314. ［44］LOUWSMA J，BRUNGER A F，BIJZET J，et al. Neurofilament
［33］VAN DEN BERGH P Y K，VAN DOORN P A，HADDEN R light chain，a biomarker for polyneuropathy in systemic
D M，et al. European Academy of Neurology/Peripheral Nerve amyloidosis［J］. Amyloid，2021，28（1）：50-55. DOI：
Society guideline on diagnosis and treatment of chronic inflammatory 10.1080/13506129.2020.1815696.
demyelinating polyradiculoneuropathy: report of a joint Task Force- ［45］LUIGETTI M，DI PAOLANTONIO A，GUGLIELMINO V，et al.
Second revision［J］. Eur J Neurol，2021，28（11）：3556- Neurofilament light chain as a disease severity biomarker in ATTRv:
3583. DOI：10.1111/ene.14959. data from a single-centre experience［J］. Neurol Sci，2022，
［34］STASCHEIT F，HOTTER B，KLOSE S，et al. Calprotectin in 43（4）：2845-2848. DOI：10.1007/s10072-021-05850-7.
chronic inflammatory demyelinating polyneuropathy and variants-a ［46］MEREGALLI C，FUMAGALLI G，ALBERTI P，et al.
potential novel biomarker of disease activity［J］. Front Neurol， Neurofilament light chain as disease biomarker in a rodent model of
2021，12: 723009. DOI：10.3389/fneur.2021.723009. chemotherapy induced peripheral neuropathy［J］. Exp Neurol，
［35］FUKAMI Y，IIJIMA M，KOIKE H，et al. Association of serum 2018，307: 129-132. DOI：10.1016/j.expneurol.2018.06.005.
neurofilament light chain levels with clinicopathology of chronic ［47］MEREGALLI C，FUMAGALLI G，ALBERTI P，et al.
inflammatory demyelinating polyneuropathy，including NF155 Neurofilament light chain: a specific serum biomarker of axonal
reactive patients［J］. J Neurol，2021，268（10）：3835-3844. damage severity in rat models of Chemotherapy-Induced Peripheral
DOI：10.1007/s00415-021-10537-2. Neurotoxicity［J］. Arch Toxicol，2020，94（7）：2517-2522.
［36］VAN LIEVERLOO G G A，WIESKE L，VERHAMME C， DOI：10.1007/s00204-020-02755-w.
et al. Serum neurofilament light chain in chronic inflammatory ［48］KIM S H，CHOI M K，PARK N Y，et al. Serum neurofilament
demyelinating polyneuropathy［J］. J Peripher Nerv Syst，2019， light chain levels as a biomarker of neuroaxonal injury and severity of
24（2）：187-194. DOI：10.1111/jns.12319. oxaliplatin-induced peripheral neuropathy［J］. Sci Rep，2020，
［37］H AYASH I T ，NUKUI T ，P IAO J L ，et al. Serum 10（1）：7995. DOI：10.1038/s41598-020-64511-5.
neurofilament light chain in chronic inflammatory demyelinating ［49］HUEHNCHEN P，SCHINKE C，BANGEMANN N，et al.
polyneuropathy［J］. Brain Behav，2021，11（5）：e02084. Neurofilament proteins as a potential biomarker in chemotherapy-
DOI：10.1002/brb3.2084. induced polyneuropathy［J］. JCI Insight，2022，7（6）：
［38］GODELAINE J，DE SCHAEPDRYVER M，BOSSUYT X，et al. e154395. DOI：10.1172/jci.insight.154395.
Prognostic value of neurofilament light chain in chronic inflammatory ［50］CELIKBILEK A，TANIK N，SABAH S，et al. Elevated
demyelinating polyneuropathy［J］. Brain Commun，2021，3（1）： neurofilament light chain （NFL） mRNA levels in prediabetic
fcab018. DOI：10.1093/braincomms/fcab018. peripheral neuropathy［J］. Mol Biol Rep，2014，41（6）：
［39］KOIKE H，KATSUNO M. Pathophysiology of chronic inflammatory 4017-4022. DOI：10.1007/s11033-014-3270-y.
demyelinating polyneuropathy: insights into classification and ［51］MORGENSTERN J，GROENER J B，JENDE J M E，et al.
therapeutic strategy［J］. Neurol Ther，2020，9（2）：213-227. Neuron-specific biomarkers predict hypo- and hyperalgesia in
DOI：10.1007/s40120-020-00190-8. individuals with diabetic peripheral neuropathy［J］. Diabetologia，
［40］AMAADOR K，WIESKE L，KOEL-SIMMELINK M J A，et al. 2021，64（12）：2843-2855. DOI：10.1007/s00125-021-
Serum neurofilament light chain，contactin-1 and complement 05557-6.
activation in anti-MAG IgM paraprotein-related peripheral （收稿日期：2022-05-30；修回日期：2022-07-30）
neuropathy［J］. J Neurol，2022，269（7）：3700-3705. DOI： （本文编辑：毛亚敏）